Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus

FY 2022-23

Summary
Staphylococcus aureus (SA) pneumonia infections are widespread in Canada, particularly in hospitalized patients, and are associated with high mortality rates (exceeding 20%), prolonged hospital stays, and significant financial costs. Although widely considered to be an extracellular microbe, recent evidence has demonstrated this bacterium has capacity to survive and replicate within organ-specific immune cells. By residing within these cells, SA can hide from host defences and remain largely resistant to elimination by antibiotics which act extracellularly. Consequently, these reservoirs of bacteria can cause persistent infection following failure of the immune system and antibiotics to clear the bacteria. Therefore, it is paramount to investigate treatments designed to target these intracellular reservoirs. We propose to use a novel human three-dimensional lung on chip (LoC) to investigate if alveolar macrophages (AMs), the lung’s resident immune cell, allow for intracellular survival and replication of SA. Using the LoC device, which includes multiple human cell types from the lung microenvironment, will allow findings to be applied directly to human disease. First, we will integrate a physiologic model of AMs into the LoC device and benchmark this by comparing our model to data generated using primary human AMs. Next, we will assess the extracellular and intracellular survival of SA in the LoC. Finally, we will test the ability of a new antibiotic formulation to selectively target these intracellular bacterial reservoirs. We anticipate this work will clarify understanding of human AMs in SA infection as well as provide preliminary evidence regarding therapeutics to target these intracellular bacteria.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
485971
Name
Nelson Theodore
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alveolar Macrophage; Antibiotics; Bacterial Infections; Human Lung-On-Chip; Intracellular Survival; Pneumonia; Staphylococcus Aureus
Abstract
Staphylococcus aureus (SA) pneumonia infections are widespread in Canada, particularly in hospitalized patients, and are associated with high mortality rates (exceeding 20%), prolonged hospital stays, and significant financial costs. Although widely considered to be an extracellular microbe, recent evidence has demonstrated this bacterium has capacity to survive and replicate within organ-specific immune cells. By residing within these cells, SA can hide from host defences and remain largely resistant to elimination by antibiotics which act extracellularly. Consequently, these reservoirs of bacteria can cause persistent infection following failure of the immune system and antibiotics to clear the bacteria. Therefore, it is paramount to investigate treatments designed to target these intracellular reservoirs. We propose to use a novel human three-dimensional lung on chip (LoC) to investigate if alveolar macrophages (AMs), the lung’s resident immune cell, allow for intracellular survival and replication of SA. Using the LoC device, which includes multiple human cell types from the lung microenvironment, will allow findings to be applied directly to human disease. First, we will integrate a physiologic model of AMs into the LoC device and benchmark this by comparing our model to data generated using primary human AMs. Next, we will assess the extracellular and intracellular survival of SA in the LoC. Finally, we will test the ability of a new antibiotic formulation to selectively target these intracellular bacterial reservoirs. We anticipate this work will clarify understanding of human AMs in SA infection as well as provide preliminary evidence regarding therapeutics to target these intracellular bacteria.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nelson, Theodore
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~